ALB and neoplasm: In 2016, Lee et al. prepared a kind of albumin nanoparticles that accumulated in the tumor site of an HCT116 cell-xenograft mouse model, and the results demonstrated excellent tumor targetability via a GP60-mediated transcytosis mechanism (Lee et al., 2016).